Clinical Trial: A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Adults at High Risk of Severe RSV Disease
Study Status: ACTIVE_NOT_RECRUITING
Recruit Status: ACTIVE_NOT_RECRUITING
Condition: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Study Type: INTERVENTIONAL
Official Title: A PHASE 3 PROTOCOL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF RESPIRATORY SYNCYTIAL VIRUS (RSV) PREFUSION F SUBUNIT VACCINE IN ADULTS AT HIGH RISK OF SEVERE RSV DISEASE
Brief Summary:
The purpose of this study is to learn about the safety and immunogenicity of a study vaccine (called RSVpreF) in several adult groups.Respiratory Syncytial Virus (RSV) is a common type of virus (germ) that can cause severe illness, where medical help is needed.RSV can lead to airway diseases in all ages.Vaccines help your body make antibodies which help fight against diseases.This is called an immune response.This study will measure how much antibody participants make after receiving RSVpreF (immunogenicity).The…
Read more